Showing results (111-120 of 291) with videos related to

Sort By:
Pageof 30
Best Practice & Research. Clinical Haematology|September 20, 2011
Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in childrenPatrick Schlegel, Heiko-Manuel Teltschik, Matthias Pfeiffer, et al.
Best Practice & Research. Clinical Haematology|September 20, 2011
Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donorsPeter Lang, Matthias Pfeiffer, Heiko-Manuel Teltschik, et al.
Cytotherapy|October 7, 2011
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cellsEva Rettinger, Selim Kuçi, Ivonne Naumann, et al.
Frontiers in Pediatrics|August 8, 2014
SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination TherapyEva Rettinger, Andreas Glatthaar, Behnaz Ahangarian Abhari, et al.
Frontiers in Immunology|February 16, 2017
Treatment of Infantile Inflammatory Bowel Disease and Autoimmunity by Allogeneic Stem Cell Transplantation in LPS-Responsive Beige-Like Anchor DeficiencyShahrzad Bakhtiar, Laura Gámez-Díaz, Andrea Jarisch, et al.
Cancers|April 3, 2021
Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen ReceptorLeonie D H Gossel, Catrin Heim, Lisa-Marie Pfeffermann, et al.
British Journal of Haematology|February 24, 2005
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapyPeter Bader, Charlotte Niemeyer, Andre Willasch, et al.
Haematologica|April 10, 2010
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantationSelim Kuçi, Eva Rettinger, Bernhard Voss, et al.
Transplantation and Cellular Therapy|April 26, 2022
Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell AplasiaAndrea Jarisch, Eliza Wiercinska, Sabine Huenecke, et al.
Bone Marrow Transplantation|May 26, 2018
Favorable immune recovery and low rate of GvHD in children transplanted with partially T cell-depleted PBSC graftsChristian Martin Seitz, Matthias Eyrich, Johann Greil, et al.
Pageof 30